This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Molybdenum trioxide
- DrugBank Accession Number
- DB15924
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
Structure for Molybdenum trioxide (DB15924)
- Weight
- Average: 143.95
Monoisotopic: 145.890149 - Chemical Formula
- MoO3
- Synonyms
- Not Available
- External IDs
- 215-204-7
- NSC-215191
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image VITAHEALTH SELENIUM VITAPLUS TABLET Molybdenum trioxide (100 µg) + Ascorbic acid (150 mg) + Magnesium (7.5 mg) + Manganese gluconate (1.5 mg) + Pyridoxine hydrochloride (15 mg) + Vitamin A palmitate (2500 IU) + Yeast (62.5 mg) + Zinc gluconate (7.8 mg) + alpha-Tocopherol succinate (50 IU) Tablet Oral VITAHEALTH BIOTECH SDN BHD 2013-12-26 2017-03-29 Malaysia 
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 22FQ3F03YS
- CAS number
- 1313-27-5
- InChI Key
- JKQOBWVOAYFWKG-UHFFFAOYSA-N
- InChI
- InChI=1S/Mo.3O
- IUPAC Name
- trioxomolybdenum
- SMILES
- O=[Mo](=O)=O
References
- General References
- Not Available
- External Links
- ChemSpider
- 14118
- ChEBI
- 30627
- Wikipedia
- Molybdenum_trioxide
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Tablet Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP -1.1 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 51.21 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 4.33 m3·mol-1 Chemaxon Polarizability 5.15 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at November 23, 2020 21:31 / Updated at November 25, 2020 17:34